trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['t-dxd']
 #asco23 t-dxd equally effective in patients over 65 but also more toxic with more grade 3 toxicities.
Breast med oncology, chief hem/onc @NYPBrooklyn, prof clinical med @WeillCornell, ethics/spirituality in medicine; long time NY #Jets sufferer; tweets my own